With reference to earlier letters dated July 09, 2015, July 20, 2015, July 21, 2015, November 27, 2015, December 10, 2015, January 21, 2016, February 16, 2016 and March 01, 2016, Cipla has now informed that the Board of Directors of Cipla Health, a subsidiary of the Company, at their meeting held on April 12, 2016 allotted shares to FIL Capital Investments (Mauritius) II Limited and consequently, the transaction has now been completed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1674.70 |
| Dr. Reddys Lab | 1236.80 |
| Cipla | 1235.95 |
| Zydus Lifesciences | 939.75 |
| Lupin | 2328.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: